New combo pill and injection aims to control leukemia in frail patients
Disease control
Recruiting now
This study tests a combination of two drugs—ivosidenib (a daily pill) and azacitidine (an injection or infusion)—in adults newly diagnosed with a type of acute myeloid leukemia (AML) that has an IDH1 gene mutation. The participants are not healthy enough for standard intensive ch…
Phase: PHASE3 • Sponsor: Servier Affaires Médicales • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC